the future of ambulatory care in the treatment of hematological conditions and malignancies
Published 3 months ago • 77 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:05
the cost-effectiveness of car t-cell therapy
-
3:10
the importance of nutrition in hematology and cancer care
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
1:13
selecting conditioning regimens for patients with myelofibrosis undergoing allosct
-
1:53
preclinical research for the future of cellular therapies
-
1:14
highlights in quality management from ebmt
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
3:02
the effects of maintenance therapy on real-world outcomes for patients with ndmm
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:02
maintenance therapy following treatment for amyloidosis
-
2:09
the importance of involving patients in research
-
0:52
tocilizumab for aa amyloidosis
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:48
do all patients require maintenance therapy following allosct?
-
1:18
the epidemiology and treatment of chronic gvhd post-allosct
-
1:29
preventing the risk of infection in patients with b-cell malignancies in the era of novel agents